Tandem Diabetes (TNDM) Misses Q3 EPS by 3c

Tandem Diabetes (NASDAQ: TNDM) reported Q3 EPS of ($0.51), $0.03 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $185.6 million versus the consensus estimate of $192.89 million.

For earnings history and earnings-related data on Tandem Diabetes (TNDM) click here.

You May Also Be Interested In

• Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
• BAE Systems Plc (BA:LN) (BAESY) New Top Pick in EU Defence at Morgan Stanley
• Goldman Sachs Upgrades Primoris Services Corporation (PRIM) to Neutral